期刊文献+

D-二聚体在肝脏疾病中测定的临床意义 被引量:9

Clinical Significance of D-Dimer Assay in Patients with Liver Diseases
原文传递
导出
摘要 对120例各类肝病进行了D-二聚体测定,其中包括急性黄疸性肝炎23例,慢性活动性肝炎30例,肝硬化代偿期40例,肝硬化失代偿期11例,原发性肝癌16例,其阳性率分别为34.78%、33.33%、62.50%、100%与68.75%。表明各类肝病呈现出不同程度的纤溶亢进现象,构成了出血倾向的综合原因之一。 D-Dirner was assayed in 120 patients with different liver diseases, including 23 cases of acute icteric hepatitis, 30 cases chronic active hepatitis, 40 in compensatory stage and 11 in incompensatory stage of the liver cirrhosis, 16 primary carcinoma of liver. The results showed that the positive rates are 34. 78%, 33.33%, 62.50%, 100%, and 68.75%, respectively, and indicated that different degree of hyperfibrinolysis exists in various liver diseases, it is one of many complex causes of bleeding tendency in liver diseases complicated with hyperfibrinolisis and DIC, the indication of anti-fibrinolisis therapy were discussed in this article.
出处 《临床消化病杂志》 1997年第1期19-20,共2页 Chinese Journal of Clinical Gastroenterology
关键词 D二聚体 纤溶亢进 肝疾病 测定 D-Dimer Hyperfibrinolysis
  • 相关文献

同被引文献51

引证文献9

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部